M Haleem A. Cytogenetic Response Assessment to Imatinib Mesylate Therapy for Chronic Myeloid Leukemia in Iraqi Patients. djm [Internet]. 2020 Jun. 2 [cited 2025 Sep. 27];18(2):113-20. Available from: https://www.djm.uodiyala.edu.iq/index.php/djm/article/view/560